BioSpace News Archive

During his trade mission trip to Israel, Florida Gov. Ron DeSantis announced a new agreement between Florida Atlantic University and Insightec, a global health care company headquartered in Haifa, Israel.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced it will report its first quarter 2023 financial results and operational highlights at 8:30 a.m. EDT on Tuesday, May 9, 2023.

Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.

Viscient Bio, Inc. (“Viscient”) today announced it has identified the world’s first drug candidate discovered primarily using 3D bioprinted tissue models of disease formed from human cells.

PharmaJet,® a company engineering Precision Delivery Systems™ that may overcome the challenges of vaccines and pharmaceuticals delivery announced that Nathalie Landry, has been appointed Chief Scientific Officer.

Children’s Hospital of Philadelphia has named Thomas F. Kolon, MD, as Chief of the Division of Urology.

Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”) today announced that it plans to release unaudited financial results for the first quarter ended March 31, 2023 and provide an update on recent developments prior to the open of the U.S. financial markets on Monday, May 15, 2023.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced it will be participating in the upcoming BofA Securities Healthcare Conference in Las Vegas, NV.

Hillstream BioPharma, Inc. announced the closing of its previously announced public offering of common stock.

Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, reported financial results for the quarter ended March 31, 2023.